A growing body of experimental evidence indicates that the process of central nervous system (CNS) remyelination by cells of the oligodendrocyte lineage occurs concomitantly with ongoing autoimmune- mediated demyelinating disease. However, the attempt to remyelinate is incomplete. Recent studies have shown that specific growth factors developmentally regulate proliferation, differentiation, and regeneration of oligodendrocytes. We propose that delivery of remyelination growth factors in the autoimmune inflammatory milieu may stimulate the remyelination process and therapeutically modulate autoimmune-mediated demyelination. We have recently shown that autoreactive T cells can be stably transfected so that therapeutic transgene products, such as interleukin- 10 (IL-10), are secreted inducibly only upon activation of the T cell with self-antigen. We have also shown that IL-10 transfected T cell clones are effective in preventing and treating experimental autoimmune encephalomyelitis (EAE), an animal model widely used in multiple sclerosis (MS) research. Our preliminary data in the present proposal show that genetically modified autoreactive T cell clones can secrete transgene remyelination growth factors in a non-constitutive antigen- inducible manner. We hypothesize that the antigen-specificity and migratory properties of memory T cells provide a model endogenous vector system for site- specific delivery of therapeutic transgene remyelination growth factors to autoimmune inflammatory lesions. We propose to use genetically- modified autoreactive memory T cells to mediate CNS remyelination during the development of EAE.
Our specific aims i n the present study are: 1) to generate a series of transgene constructs designed to provide expression of various remyelination growth factors upon T cell engagement with self-antigen; 2) to isolate and characterize transfected autoreactive T cell clones expressing transgene remyelination growth factors; 3) to determine the biologic activity of transgene remyelination growth factors produced by transfected autoreactive T cells; and 4) to determine the ability of autoreactive T cells transfected with remyelination growth factors to regenerate CNS tissue during EAE. Our proposed experiments will directly determine appropriate choices of remyelination growth factors for use in vivo to the treatment of MS, and in broader sense will provide a rational basis for the development of a novel gene therapy approach for genetically modulation autoimmune disease in general.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS037476-03
Application #
6351859
Study Section
Special Emphasis Panel (ZRG1-BDCN-4 (01))
Program Officer
Utz, Ursula
Project Start
1999-02-01
Project End
2003-01-31
Budget Start
2001-02-01
Budget End
2002-01-31
Support Year
3
Fiscal Year
2001
Total Cost
$227,282
Indirect Cost
Name
Cleveland Clinic Lerner
Department
Type
DUNS #
017730458
City
Cleveland
State
OH
Country
United States
Zip Code
44195
Altuntas, Cengiz Z; Johnson, Justin M; Tuohy, Vincent K (2006) Autoimmune targeted disruption of the pituitary-ovarian axis causes premature ovarian failure. J Immunol 177:1988-96
Jaini, Ritika; Hannaman, Drew; Johnson, Justin M et al. (2006) Gene-based intramuscular interferon-beta therapy for experimental autoimmune encephalomyelitis. Mol Ther 14:416-22
Edling, Andrea E; Tuohy, Vincent K (2005) Stem cell reconstitution of autoimmune T cell repertoires. J Neuroimmunol 169:126-36
Edling, Andrea E; Nanavati, Tania; Johnson, Justin M et al. (2004) Human and murine lymphocyte neurotrophin expression is confined to B cells. J Neurosci Res 77:709-17
Solares, C Arturo; Edling, Andrea E; Johnson, Justin M et al. (2004) Murine autoimmune hearing loss mediated by CD4+ T cells specific for inner ear peptides. J Clin Invest 113:1210-7
Solares, C Arturo; Hughes, Gordon B; Tuohy, Vincent K (2003) Autoimmune sensorineural hearing loss: an immunologic perspective. J Neuroimmunol 138:1-7
Lorenz, Robert R; Solares, C Arturo; Williams, Paul et al. (2002) Interferon-gamma production to inner ear antigens by T cells from patients with autoimmune sensorineural hearing loss. J Neuroimmunol 130:173-8
Wujek, Jerome R; Bjartmar, Carl; Richer, Edward et al. (2002) Axon loss in the spinal cord determines permanent neurological disability in an animal model of multiple sclerosis. J Neuropathol Exp Neurol 61:23-32
Jane-wit, Daniel; Yu, Min; Edling, Andrea E et al. (2002) A novel class II-binding motif selects peptides that mediate organ-specific autoimmune disease in SWXJ, SJL/J, and SWR/J mice. J Immunol 169:6507-14
Yin, L; Yu, M; Edling, A E et al. (2001) Pre-emptive targeting of the epitope spreading cascade with genetically modified regulatory T cells during autoimmune demyelinating disease. J Immunol 167:6105-12

Showing the most recent 10 out of 19 publications